IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts

Carcinogenesis

Volumn 34, Issue 11, 2013, Pages 2647-2654

  Hamilton, Kathryn E ^a   Noubissi, Felicite K ^b   Katti, Prateek S ^a   Hahn, Christopher M ^a   Davey, Sonya R ^a   Lundsmith, Emma T ^a   Klein Szanto, Andres J ^c   Rhim, Andrew D ^a   Spiegelman, Vladimir S ^b   Rustgi, Anil K ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IGF2 MRNA BINDING PROTEIN 1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; COLORECTAL CANCER; GENE; HUMAN; HUMAN CELL; IGF2 MRNA BINDING PROTEIN 1 GENE; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; EMBRYO, MAMMALIAN; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; HETEROGRAFTS; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRASES; INTESTINES; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PHENOTYPE; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 84885905136     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt217     Document Type: Article

References (40)

1. Leeds,P.et al. (1997) Developmental regulation of CRD-BP, an RNAbinding protein that stabilizes c-myc mRNA in vitro. Oncogene, 14, 1279-1286.
2. Ross,A.F.et al. (1997) Characterization of a beta-actin mRNA zipcodebinding protein. Mol. Cell. Biol., 17, 2158-2165.
3. Doyle,G.A.et al. (1998) The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res., 26, 5036-5044.
4. Nielsen,J.et al. (1999) A family of insulin-like growth factor II mRNAbinding proteins represses translation in late development. Mol. Cell. Biol., 19, 1262-1270.
5. Hansen,T.V.et al. (2004) Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol. Cell. Biol., 24, 4448-4464.
6. Ross,J.et al. (2001) Overexpression of an mRNA-binding protein in human colorectal cancer. Oncogene, 20, 6544-6550.
7. Tessier,C.R.et al. (2004) Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res., 64, 209-214.
8. Elcheva,I.et al. (2008) Overexpression of mRNA-binding protein CRD-BP in malignant melanomas. Oncogene, 27, 5069-5074.
9. Kato,T.et al. (2007) Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin. Cancer Res., 13(Pt 1), 434-442.
10. Dimitriadis,E.et al. (2007) Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer. Int. J. Cancer, 121, 486-494.
11. Lapidus,K.et al. (2007) ZBP1 enhances cell polarity and reduces chemotaxis. J. Cell Sci., 120(Pt 18), 3173-3178.
12. Oberman,F.et al. (2007) VICKZ proteins mediate cell migration via their RNA binding activity. RNA, 13, 1558-1569.
13. Vainer,G.et al. (2008) A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation. J. Pathol., 215, 445-456.
14. Noubissi,F.K.et al. (2006) CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature, 441, 898-901.
15. Stöhr,N.et al. (2012) IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. Genes Dev., 26, 176-189.
16. Manieri,N.A.et al. (2012) Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. Gastroenterology, 143, 110-21.e10.
17. Mongroo,P.S.et al. (2011) IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. Cancer Res., 71, 2172-2182.
18. King,C.E.et al. (2011) LIN28B promotes colon cancer progression and metastasis. Cancer Res., 71, 4260-4268.
19. Spiegelman,V.S.et al. (2000) Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol. Cell, 5, 877-882.
20. Rhim,A.D.et al. (2012) EMT and dissemination precede pancreatic tumor formation. Cell, 148, 349-361.
21. Kanwar,S.S.et al. (2010) The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol. Cancer, 9, 212.
22. Leibovitz,A.et al. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36, 4562-4569.
23. Noubissi,F.K.et al. (2009) Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. Cancer Res., 69, 8572-8578.
24. Li,D.et al. (2009) IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann. Surg. Oncol., 16, 3499-3506.
25. Lochhead,P.et al. (2012) Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. Eur. J Cancer, 48, 3405-3413.
26. Faltas,B. (2012) Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells. Front. Oncol., 2, 68.
27. Yu,Y.et al. (2009) Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX. Transl. Oncol., 2, 321-328.
28. Weichert,W.et al. (2005) Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin. Cancer Res., 11, 6574-6581.
29. Choi,D.et al. (2009) Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J. Gastroenterol., 15, 2258-2264.
30. Herrmann,I.et al. (2010) Highly efficient elimination of colorectal tumorinitiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells. PLoS One, 5, e13474.
31. Yeung,T.M.et al. (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc. Natl Acad. Sci. USA, 107, 3722-3727.
32. Boyerinas,B.et al. (2012) Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance Int. J. Cancer, 130, 1787-1797.
33. Hüsemann,Y.et al. (2008) Systemic spread is an early step in breast cancer. Cancer Cell, 13, 58-68.
34. Eyles,J.et al. (2010) Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest., 120, 2030-2039.
35. Cameron,M.D.et al. (2000) Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res., 60, 2541-2546.
36. Psaila,B.et al. (2009) The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer, 9, 285-293.
37. Oskarsson,T.et al. (2011) Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med., 17, 867-874.
38. Dieter,S.M.et al. (2011) Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell, 9, 357-365.
39. Onder,T.T.et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res., 68, 3645-3654.
40. Vikesaa,J.et al. (2006) RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J., 25, 1456-1468.